The Pharmacogenetic Footprint of ACE Inhibition: A Population-Based Metabolomics Study

SNiPA: an interactive, genetic variant-centered annotation browser

(2014) Matthias Arnold et al.   BIOINFORMATICS

Metabolomics approach reveals effects of antihypertensives and lipid-lowering drugs on the human metabolism

(2014) Elisabeth Altmaier et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

An atlas of genetic influences on human blood metabolites

(2014) So-Youn Shin et al.   NATURE GENETICS

Genetic Determinants Influencing Human Serum Metabolome among African Americans

(2014) Bing Yu et al.   PLoS Genetics

Three key proteases – angiotensin-I-converting enzyme (ACE), ACE2 and renin – within and beyond the renin-angiotensin system

(2012) Cuie Guang et al.   Archives of Cardiovascular Diseases

On the hypothesis-free testing of metabolite ratios in genome-wide and metabolome-wide association studies

(2012) Ann-Kristin Petersen et al.   BMC BIOINFORMATICS

Mining the Unknown: A Systems Approach to Metabolite Identification Combining Genetic and Metabolic Information

(2012) Jan Krumsiek et al.   PLoS Genetics

Human metabolic individuality in biomedical and pharmaceutical research

(2011) Karsten Suhre et al.   NATURE

A genome-wide association study identifies new loci for ACE activity: potential implications for response to ACE inhibitor

(2010) C-M Chung et al.   PHARMACOGENOMICS JOURNAL

Integrated, Nontargeted Ultrahigh Performance Liquid Chromatography/Electrospray Ionization Tandem Mass Spectrometry Platform for the Identification and Relative Quantification of the Small-Molecule Complement of Biological Systems

(2009) Anne M. Evans et al.   ANALYTICAL CHEMISTRY